Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Galapagos' drug also active against Crohn's disease!

Galapagos has been working for a while on a drug, called Filgotinib, against rheumatoid arthritis. But this drug candidate also appears to have ot…


Galapagos finally managed to close long awaited deal

Earlier this year, AbbVie turned down its deal with Galapagos for co-development and commercializiation of the drug filgotinib for treatment of re…


TiGenix inks massive deal with Takeda

Today cell therapy specialist TiGenix has disclosed a new deal with the Japanese pharmaceutical giant Takeda. The agreement allows Takeda the righ…

POPULAR TAGS

Major breakthrough in Tigenix' Crohn's research

Written by DS on in the category news with the tags .


About one year ago, patients received a single injection of Cx601. Half of the patients were healed after 24 weeks. One year later, 1 in 2 (54%) patients still experiences the positive effect of the drug. This is very good news for TiGenix, because if diseases can be cured with a single injection, the probability increases that the product will be reimbursed by the health insurance. Previous studies already showed that the treatment has a favorable safety profile. Moreover, these results equip TiGenix with extra leverage to go to investors and pharma companies. The biotech company is looking for a pharmaceutical company to fund the last stage of the clinical trial in the US and wants to make an IPO on NASDAQ.

Read more about: .

RELATED ARTICLES
Galapagos' drug also active against Crohn's disease!

Galapagos has been working for a while on a drug, called Filgotinib, against rheumatoid arthritis. But this drug candidate also appears to have ot…


Galapagos finally managed to close long awaited deal

Earlier this year, AbbVie turned down its deal with Galapagos for co-development and commercializiation of the drug filgotinib for treatment of re…


TiGenix inks massive deal with Takeda

Today cell therapy specialist TiGenix has disclosed a new deal with the Japanese pharmaceutical giant Takeda. The agreement allows Takeda the righ…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Itera Life Science GSK Biowin UGent Janssen XpandInnovation V-Bio Ventures Turnstone KU Leuven Flanders.bio

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.